Clinical review: Corticotherapy in sepsis

Critical Care

Volumn 8, Issue 2, 2004, Pages 122-129

  Prigent, Helene ^a   Maxime, Virginie ^a   Annane, Djillali ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Adrenal insufficiency; Glucorticoids; Hormone replacement therapy; Hypothalamic pituitary adrenal axis; Sepsis

Indexed keywords

FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE;

ADRENAL INSUFFICIENCY; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; DRUG MEGADOSE; HORMONE RESISTANCE; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INTENSIVE CARE; METABOLISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPSIS; SEPTIC SHOCK; STEROID THERAPY; STEROIDOGENESIS; STRESS;

CRITICAL CARE; EPINEPHRINE; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NOREPINEPHRINE; PITUITARY-ADRENAL SYSTEM; SHOCK, SEPTIC;

EID: 1842530882     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2374     Document Type: Review

References (49)

1. Orth DN, Kovacs WJ, DeBold CR: The Adrenal Cortex. In Williams Textbook of Endocrinology. Edited by Wilson JD, Foster DW. Philadelphia: W.B. Saunders Company; 1992:489-531.
2. Almawi WY: Molecular mechanisms of glucocorticoid effects. Mod Asp Immunobiol 2001, 2:78-82.
3. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O'Shea JJ, Chrousos GP, Bornstein SR: Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002, 16:61-71.
4. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995, 332: 1351-1362.
5. Cavaillon JM: Action of glucocorticoids in the inflammatory cascade [in French]. Réanim Urgences 2000, 9:605-612.
6. Tsigos C, Chrousos GP: Hypothalamic-pituitary-adrenal axis, nauroendocrine factors and stress. J Psychosom Res 2002, 53:865-871.
7. Marik PE, Zaloga GP: Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002, 122:1784-1796.
8. Pilkis SJ, Granner DK: Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 1992, 54:885-909.
9. Chrousos GP: The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture. In Neuroimmunomodulation. Perspectives at the New Millennium. Edited by Conti A, Maestroni JM, McCann SM, Sternberg EM, Lipton JM, Smith CC. New York: Ann NY Acad Sci; 2000:38-67.
10. Beishuizen A, Thijs LG, Haanen C, Vermes I: Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 2001, 86: 2811-2816.
11. Beishuizen A, Vermes I, Hylkema BS, Haanen C: Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 1999, 353:1675-1676.
12. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H: Immunologic and hemodynamic effects of 'low-dose' hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003, 167: 512-520.
13. Beishuizen A, Thijs LG: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res 2003, 9:3-24.
14. Soni A, Pepper GM, Wyrwinski PM, Ramirez NE, Simon R, Pina T, Gruenspan H, Vaca CE: Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995, 98:266-271.
15. Franchimont D, Martens H, Hagelstein MT, Louis E, Dewe W, Chrousos GP, Belaiche J, Geenen V: Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 1999, 84:2834-2839.
16. Muller B, Peri G, Doni A, Perruchoud AP, Landmann R, Pasqualini F, Mantovani A: High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol 2002, 72:643-649.
17. Briegel J, Kellermann W, Forst H, Haller M, Bittl M, Hoffmann GE, Buchler M, Uhl W, Peter K: Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group. Clin Invest 1994, 72:782-787.
18. Annane D, Bellissant E: Impact of corticosteroids on the vascular response to catecholamines in septic shock. Réanimation 2002, 11:111-116.
19. Lamberts SW, Bruining HA, de Jong FH: Corticosteroid therapy in severe illness. N Engl J Med 1997, 337:1285-1292.
20. Beishuizen A, Thijs LG, Vermes I: Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001, 27:1584-1591.
21. Schroeder S, Wichers M, Klingmuller D, Hofer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stuber F: The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med 2001, 29:310-316.
22. Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993, 77:1690-1694.
23. McKee JI, Finlay WE: Cortisol replacement in severely stressed patients [letter]. Lancet 1983, 1:484.
24. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003, 348:727-734.
25. Streeten DH: What test for hypothalamic-pituitary-adrenocortical insufficiency? Lancet 1999, 354:179-180.
26. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
27. Jurney TH, Cockrell JL Jr, Lindberg JS, Lamiell JM, Wade CE: Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality. Chest 1987, 92:292-295.
28. Loisa P, Rinne T, Kaukinen S: Adrenocortical function and multiple organ failure in severe sepsis. Acta Anaesthesiol Scand 2002, 46:145-151.
29. Span LF, Hermus AR, Bartelink AK, Hoitsma AJ, Gimbrere JS, Smals AG, Kloppenborg PW: Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med 1992, 18:93-96.
30. Schein RM, Sprung CL, Marcial E, Napolitano L, Chernow B: Plasma cortisol levels in patients with septic shock. Crit Care Med 1990, 18:259-263.
31. Rothwell PM, Lawler PG: Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995, 23:78-83.
32. Chernow B, Alexander HR, Smallridge RC, Thompson WR, Cook D, Beardsley D, Fink MP, Lake CR, Fletcher JR: Hormonal responses to graded surgical stress. Arch Intern Med 1987, 147:1273-1278.
33. Rothwell PM, Udwadia ZF, Lawler PG: Cortisol response to corticotropin and survival in septic shock. Lancet 1991, 337:582-583.
34. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000, 283:1038-1045.
35. Anonymous: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group. N Engl J Med 1987, 317:659-665.
36. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987, 317:653-658.
37. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ Jr: Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995, 23:1430-1439.
38. Annane D, Raphael JC, Gajdos P: Are endogenous glucocorticoid levels adequate in septic shock? Intensive Care Med 1996, 22:711-712.
39. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003, 31:141-145.
40. Moran JL, Chapman MJ, O'Fathartaigh MS, Peisach AR, Pannall PR, Leppard P: Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 1994, 20:489-495.
41. Rothwell PM, Udwadia ZF, Jackson EA, Lawler PJ: Plasma cortisol levels in patients with septic shock. Crit Care Med 1991, 19:589-590.
42. Briegel J, Schelling G, Haller M, Mraz W, Forst H, Peter K: A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med 1996, 22:894-899.
43. Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, Moldawer LL, Lowry SF: Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993, 150:1999-2006.
44. Bhagat K, Collier J, Vallance P: Local venous responses to endotoxin in humans. Circulation 1996, 94:490-497.
45. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K: Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999, 27:723-732.
46. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998, 26:645-650.
47. Bellissant E, Annane D: Effect of hydrocortisone on phenylephrine: mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther 2000, 68:293-303.
48. Annane D, Bellissant E, Sebille V, Lesieur O, Mathieu B, Raphael JC, Gajdos P: Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998, 46:589-597.
49. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.